AAPL335.29+8.72 (+2.67%) ▲|ABBV256.43+1.43 (+0.56%) ▲|ABT103.57+0.20 (+0.19%) ▲|ACN180.39+2.49 (+1.40%) ▲|ADBE245.07-3.76 (-1.51%) ▼|AMAT457.40+3.39 (+0.75%) ▲|AMD503.03-0.57 (-0.11%) ▼|AMGN384.30+1.83 (+0.48%) ▲|AMT175.60+2.61 (+1.51%) ▲|AMZN256.21+4.32 (+1.72%) ▲|AVGO363.48+2.65 (+0.73%) ▲|AXP324.91+4.18 (+1.30%) ▲|BA208.54+3.69 (+1.80%) ▲|BAC63.78+1.21 (+1.93%) ▲|BKNG174.28+0.37 (+0.21%) ▲|BLK1,080.99+18.45 (+1.74%) ▲|BMY64.05+0.31 (+0.48%) ▲|BNY164.33+1.72 (+1.05%) ▲|BRK-B509.04+2.03 (+0.40%) ▲|C140.92+2.39 (+1.72%) ▲|CAT817.78+12.78 (+1.59%) ▲|CL88.34+0.45 (+0.51%) ▲|CMCSA25.31+0.14 (+0.54%) ▲|COF210.58+3.49 (+1.69%) ▲|COP135.82-1.23 (-0.90%) ▼|COST905.11+2.73 (+0.30%) ▲|CRM247.90+4.80 (+1.97%) ▲|CSCO109.40+1.96 (+1.82%) ▲|CVS96.04+0.75 (+0.79%) ▲|CVX213.29+0.53 (+0.25%) ▲|DE689.56+11.61 (+1.71%) ▲|DHR202.36+1.88 (+0.94%) ▲|DIS106.49+0.64 (+0.61%) ▲|DUK119.81+0.41 (+0.34%) ▲|EMR150.20+1.82 (+1.23%) ▲|FDX314.52+2.70 (+0.86%) ▲|GD355.64+1.35 (+0.38%) ▲|GE328.12+4.00 (+1.23%) ▲|GEV950.00+26.61 (+2.88%) ▲|GILD145.64+0.83 (+0.57%) ▲|GM87.15+1.05 (+1.22%) ▲|GOOG337.20+6.81 (+2.06%) ▲|GOOGL339.35+6.75 (+2.03%) ▲|GS1,037.83+18.10 (+1.77%) ▲|HD311.00+5.30 (+1.73%) ▲|HON203.43+1.25 (+0.62%) ▲|IBM236.56+2.49 (+1.06%) ▲|INTC101.41+1.09 (+1.08%) ▲|INTU318.36+5.59 (+1.79%) ▲|ISRG372.53+12.07 (+3.35%) ▲|JNJ269.03+2.69 (+1.01%) ▲|JPM359.72+6.23 (+1.76%) ▲|KO88.40+0.57 (+0.65%) ▲|LIN464.16+2.54 (+0.55%) ▲|LLY1,127.01+3.74 (+0.33%) ▲|LMT529.21-0.77 (-0.15%) ▼|LOW199.46+2.86 (+1.46%) ▲|LRCX299.94+1.93 (+0.65%) ▲|MA568.38+2.96 (+0.52%) ▲|MCD253.82+0.79 (+0.31%) ▲|MDLZ62.69+0.22 (+0.35%) ▲|MDT92.25+0.63 (+0.69%) ▲|META659.47+15.09 (+2.34%) ▲|MMM163.29+0.43 (+0.26%) ▲|MO69.49+0.73 (+1.06%) ▲|MRK145.06+0.34 (+0.23%) ▲|MS216.60+3.89 (+1.83%) ▲|MSFT496.81+4.37 (+0.89%) ▲|MU978.18+0.77 (+0.08%) ▲|NEE82.95+0.49 (+0.59%) ▲|NFLX76.94+0.93 (+1.22%) ▲|NKE36.94+0.33 (+0.89%) ▲|NOW133.76+2.58 (+1.97%) ▲|NVDA219.49+1.13 (+0.52%) ▲|ORCL156.50+3.33 (+2.17%) ▲|PEP136.99+0.34 (+0.25%) ▲|PFE27.66+0.02 (+0.07%) ▲|PG144.83+1.83 (+1.28%) ▲|PLTR166.88+1.02 (+0.61%) ▲|PM192.68+2.95 (+1.55%) ▲|QCOM181.56+4.68 (+2.65%) ▲|RTX198.38+0.30 (+0.15%) ▲|SBUX99.78+0.56 (+0.56%) ▲|SCHW106.72-0.61 (-0.57%) ▼|SO88.21+0.46 (+0.52%) ▲|SPG205.01+0.27 (+0.13%) ▲|T25.91+0.35 (+1.35%) ▲|TMO609.66+6.51 (+1.08%) ▲|TMUS180.03+2.87 (+1.62%) ▲|TSLA364.96+1.40 (+0.38%) ▲|TXN267.37+8.55 (+3.30%) ▲|UBER72.19-0.37 (-0.51%) ▼|UNH385.23-3.05 (-0.79%) ▼|UNP287.61+1.83 (+0.64%) ▲|UPS100.00+0.03 (+0.03%) ▲|USB62.88+0.47 (+0.75%) ▲|V368.49+1.28 (+0.35%) ▲|VZ50.40+0.43 (+0.86%) ▲|WFC90.41+0.96 (+1.07%) ▲|WMT106.20+0.47 (+0.44%) ▲|XOM165.55+0.32 (+0.19%) ▲|AAPL335.29+8.72 (+2.67%) ▲|ABBV256.43+1.43 (+0.56%) ▲|ABT103.57+0.20 (+0.19%) ▲|ACN180.39+2.49 (+1.40%) ▲|ADBE245.07-3.76 (-1.51%) ▼|AMAT457.40+3.39 (+0.75%) ▲|AMD503.03-0.57 (-0.11%) ▼|AMGN384.30+1.83 (+0.48%) ▲|AMT175.60+2.61 (+1.51%) ▲|AMZN256.21+4.32 (+1.72%) ▲|AVGO363.48+2.65 (+0.73%) ▲|AXP324.91+4.18 (+1.30%) ▲|BA208.54+3.69 (+1.80%) ▲|BAC63.78+1.21 (+1.93%) ▲|BKNG174.28+0.37 (+0.21%) ▲|BLK1,080.99+18.45 (+1.74%) ▲|BMY64.05+0.31 (+0.48%) ▲|BNY164.33+1.72 (+1.05%) ▲|BRK-B509.04+2.03 (+0.40%) ▲|C140.92+2.39 (+1.72%) ▲|CAT817.78+12.78 (+1.59%) ▲|CL88.34+0.45 (+0.51%) ▲|CMCSA25.31+0.14 (+0.54%) ▲|COF210.58+3.49 (+1.69%) ▲|COP135.82-1.23 (-0.90%) ▼|COST905.11+2.73 (+0.30%) ▲|CRM247.90+4.80 (+1.97%) ▲|CSCO109.40+1.96 (+1.82%) ▲|CVS96.04+0.75 (+0.79%) ▲|CVX213.29+0.53 (+0.25%) ▲|DE689.56+11.61 (+1.71%) ▲|DHR202.36+1.88 (+0.94%) ▲|DIS106.49+0.64 (+0.61%) ▲|DUK119.81+0.41 (+0.34%) ▲|EMR150.20+1.82 (+1.23%) ▲|FDX314.52+2.70 (+0.86%) ▲|GD355.64+1.35 (+0.38%) ▲|GE328.12+4.00 (+1.23%) ▲|GEV950.00+26.61 (+2.88%) ▲|GILD145.64+0.83 (+0.57%) ▲|GM87.15+1.05 (+1.22%) ▲|GOOG337.20+6.81 (+2.06%) ▲|GOOGL339.35+6.75 (+2.03%) ▲|GS1,037.83+18.10 (+1.77%) ▲|HD311.00+5.30 (+1.73%) ▲|HON203.43+1.25 (+0.62%) ▲|IBM236.56+2.49 (+1.06%) ▲|INTC101.41+1.09 (+1.08%) ▲|INTU318.36+5.59 (+1.79%) ▲|ISRG372.53+12.07 (+3.35%) ▲|JNJ269.03+2.69 (+1.01%) ▲|JPM359.72+6.23 (+1.76%) ▲|KO88.40+0.57 (+0.65%) ▲|LIN464.16+2.54 (+0.55%) ▲|LLY1,127.01+3.74 (+0.33%) ▲|LMT529.21-0.77 (-0.15%) ▼|LOW199.46+2.86 (+1.46%) ▲|LRCX299.94+1.93 (+0.65%) ▲|MA568.38+2.96 (+0.52%) ▲|MCD253.82+0.79 (+0.31%) ▲|MDLZ62.69+0.22 (+0.35%) ▲|MDT92.25+0.63 (+0.69%) ▲|META659.47+15.09 (+2.34%) ▲|MMM163.29+0.43 (+0.26%) ▲|MO69.49+0.73 (+1.06%) ▲|MRK145.06+0.34 (+0.23%) ▲|MS216.60+3.89 (+1.83%) ▲|MSFT496.81+4.37 (+0.89%) ▲|MU978.18+0.77 (+0.08%) ▲|NEE82.95+0.49 (+0.59%) ▲|NFLX76.94+0.93 (+1.22%) ▲|NKE36.94+0.33 (+0.89%) ▲|NOW133.76+2.58 (+1.97%) ▲|NVDA219.49+1.13 (+0.52%) ▲|ORCL156.50+3.33 (+2.17%) ▲|PEP136.99+0.34 (+0.25%) ▲|PFE27.66+0.02 (+0.07%) ▲|PG144.83+1.83 (+1.28%) ▲|PLTR166.88+1.02 (+0.61%) ▲|PM192.68+2.95 (+1.55%) ▲|QCOM181.56+4.68 (+2.65%) ▲|RTX198.38+0.30 (+0.15%) ▲|SBUX99.78+0.56 (+0.56%) ▲|SCHW106.72-0.61 (-0.57%) ▼|SO88.21+0.46 (+0.52%) ▲|SPG205.01+0.27 (+0.13%) ▲|T25.91+0.35 (+1.35%) ▲|TMO609.66+6.51 (+1.08%) ▲|TMUS180.03+2.87 (+1.62%) ▲|TSLA364.96+1.40 (+0.38%) ▲|TXN267.37+8.55 (+3.30%) ▲|UBER72.19-0.37 (-0.51%) ▼|UNH385.23-3.05 (-0.79%) ▼|UNP287.61+1.83 (+0.64%) ▲|UPS100.00+0.03 (+0.03%) ▲|USB62.88+0.47 (+0.75%) ▲|V368.49+1.28 (+0.35%) ▲|VZ50.40+0.43 (+0.86%) ▲|WFC90.41+0.96 (+1.07%) ▲|WMT106.20+0.47 (+0.44%) ▲|XOM165.55+0.32 (+0.19%) ▲|
23.1 C
New York
Friday, September 11, 2026

Tag: approval

newssourceFORcompanyinformationcontent1releasesmarket

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

VICTORIA, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the second quarter of 2025 and provided a business update. All dollar values are in U.S. dollars unless stated otherwise.

Argenta Silver Announces Closing of Additional Investment of C$2.5 Million

TSX-V:AGAG VANCOUVER, BC, Aug. 12, 2025 /CNW/ - Argenta Silver Corp. (TSXV: AGAG) (FSE: T1K) ("Argenta" or the "Company") is pleased to announce the closing of...

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

•   First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026

Armata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update

Entered into secured credit agreement with Innoviva for $15 million maturing in 2029 Announced positive topline results from the Phase 1b/2a diSArm trial for AP-SA02 LOS...

Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1Pivotal Phase 3 CYPRESS study enrollment on track to complete by late...

APPLIED GRAPHITE ANNOUNCES CLOSING OF FINANCING

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, Aug. 12, 2025 /CNW/ - Applied Graphite Technologies...

Terrestrial Energy Selected for DOE Office of Nuclear Energy Advanced Reactor Pilot Program for Accelerated Development

Advanced Reactor Pilot Program launched by DOE to expedite authorization and commercialization of advanced nuclear reactor designs

Fermi America™ Names Two Highly Successful Nuclear Developers, Mesut and Sezin Uzman, to Spearhead Nuclear Power Delivery

- Seasoned global leaders have successfully supported 16 landmark nuclear projects across the UAE and China - Fermi America bringing global "Power Couple" home to...

Argenta Silver Announces Closing of Bought Deal Private Placement for Gross Proceeds of C$15 Million

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/              ...

FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

— Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung Damage — — BRINSUPRI 10...

Undervalued Gold Equities Poised for a Breakout

Equity Insider News CommentaryIssued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ -- Late last week as global equities rose,...

Undervalued Gold Equities Poised for a Breakout

Equity Insider News CommentaryIssued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ -- Late last week as global equities rose,...

Undervalued Gold Equities Poised for a Breakout

Equity Insider News CommentaryIssued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, Aug. 12, 2025 /CNW/ -- Late last week as global equities rose,...

Decisions of the Extraordinary General Meeting of Shareholders of AUGA group, AB, entity under restructuring which took place on 12th August 2025

The Extraordinary General Meeting of Shareholders of AUGA group, RAB (legal entity code 126264360, address: Konstitucijos ave. 21C, Vilnius; Company) took place on 12th August 2025, the shareholders attending the meeting held 151,504,494 shares, which entitled them to 151,504,494 votes (i.e. 64.80% of votes granted by all shares of the Company).

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsApproval

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers